Kyrgyzstan vs North Macedonia: Treatment success rate for patients treated for MDR-TB
Kyrgyzstan
75.0%
in 2022
North Macedonia
75.0%
in 2022
Kyrgyzstan rank
70th
North Macedonia rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Kyrgyzstan
- North Macedonia
How they compare
Kyrgyzstan currently reports 75.0% against 75.0% in North Macedonia, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2006 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 70th and North Macedonia ranks 70th of 163 countries.
Kyrgyzstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.8% | 13.8% | 32.0% | Kyrgyzstan |
| 2010s | 57.1% | 40.4% | 16.7% | Kyrgyzstan |
| 2020s | 74.0% | 58.3% | 15.7% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kyrgyzstan or North Macedonia?
- Kyrgyzstan, at 75.0% against 75.0% in North Macedonia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kyrgyzstan and North Macedonia?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and North Macedonia?
- 17 years are reported by both, from 2006 to 2022.
- How do Kyrgyzstan and North Macedonia rank globally for treatment success rate for patients treated for mdr-tb?
- Kyrgyzstan ranks 70th and North Macedonia ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.